Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Citius Oncology (CTOR)
- 0.7801
- +0.1003+14.75%
Close Apr 14 16:00 ET
- 0.7647
- -0.0154-1.97%
Post 16:40 ET
68.86MMarket Cap-2.52P/E (TTM)
0.7850High0.6899Low212.77KVolume0.6900Open0.6798Prev Close160.88KTurnover1.51%Turnover RatioLossP/E (Static)88.28MShares6.190052wk High1.18P/B11.02MFloat Cap0.491252wk Low--Dividend TTM14.13MShs Float49.0000Historical High--Div Yield TTM13.99%Range %0.4912Historical Low0.7560Avg Price1Lot Size
Citius Oncology (CTOR) Key Financial Indicators
CTOR Earnings per Share (EPS)
According to the latest financial report of Citius Oncology, the latest earnings per share (TTM) for the company is -0.06. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
CTOR Free Cash Flow (FCF)
Interested in knowing about Citius Oncology's free cash flow? The latest report shows it as -11.75M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
CTOR Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Citius Oncology shows that the company's current ratio is 0.83, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
CTOR Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Citius Oncology, the quick ratio is 0.25, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
CTOR Return on Equity (ROE)
Want to learn more about the financial health of Citius Oncology? The latest ROE figure is -10.72%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
CTOR Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Citius Oncology, the total asset return on investment (ROA) is -5.25%.
Currency: USD
Quarterly
Loading...
CTOR Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Citius Oncology's latest financial report to see how their gross margin is doing - currently at 79.99%.
Currency: USD
Quarterly
Loading...
CTOR Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Citius Oncology, the net profit margin is -140.31%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm